Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Self-assembled chamber-like cardiac organoids for modeling cardiac chamber formation and cardiotoxicity assessment.

Nature communications·2026
Same author

Developmental chronology of mouse embryo from 2-cell stage through birth.

Nature cell biology·2026
Same author

In vitro mimicking of humanized cardiogenesis under porcine condition.

Cell & bioscience·2026
Same author

Cryo-EM structure of TMEM164 reveals distinct phospholipid remodeling mechanisms with anti-ferroptotic potential.

Nature communications·2025
Same author

Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2.

EMBO reports·2025
Same author

Role of frustrations in cell reprogramming.

PNAS nexus·2025
Same journal

Demonstration of a quantum C-NOT gate in a time-multiplexed fully reconfigurable photonic processor.

Nature communications·2026
Same journal

Nonlinear quantum light source with van der Waals ferroelectric NbOX<sub>2</sub> (X = Br, I).

Nature communications·2026
Same journal

Antagonistic histone H2A variants and autonomous heterochromatin formation shape epigenomic patterns in Arabidopsis.

Nature communications·2026
Same journal

The long tail of nitrate pollution in groundwater challenges governance of global water quality.

Nature communications·2026
Same journal

Select microbial metabolites promote tau aggregation in a murine tauopathy model.

Nature communications·2026
Same journal

Warming climate has lengthened global intense tropical cyclone seasons.

Nature communications·2026
查看所有相关文章

相关实验视频

Updated: Jun 19, 2025

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.2K

通过理性设计的工程小鼠细胞命运控制器.

Tao Huang1,2, Dong Liu2, Xiaomin Wang2

  • 1College of Life Sciences, Zhejiang University, Hangzhou, China.

Nature communications
|July 23, 2024
PubMed
概括
此摘要是机器生成的。

工程NanogBiD通过招募Brg/Brahma关联因子 (BAF) 复合体,有效地重新编程小鼠细胞. 这种工具增强了细胞命运过渡和多能性的染色质可访问性.

更多相关视频

Loss- and Gain-of-function Approach to Investigate Early Cell Fate Determinants in Preimplantation Mouse Embryos
08:43

Loss- and Gain-of-function Approach to Investigate Early Cell Fate Determinants in Preimplantation Mouse Embryos

Published on: June 6, 2016

8.8K
Structure-function Studies in Mouse Embryonic Stem Cells Using Recombinase-mediated Cassette Exchange
15:13

Structure-function Studies in Mouse Embryonic Stem Cells Using Recombinase-mediated Cassette Exchange

Published on: April 27, 2017

10.9K

相关实验视频

Last Updated: Jun 19, 2025

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.2K
Loss- and Gain-of-function Approach to Investigate Early Cell Fate Determinants in Preimplantation Mouse Embryos
08:43

Loss- and Gain-of-function Approach to Investigate Early Cell Fate Determinants in Preimplantation Mouse Embryos

Published on: June 6, 2016

8.8K
Structure-function Studies in Mouse Embryonic Stem Cells Using Recombinase-mediated Cassette Exchange
15:13

Structure-function Studies in Mouse Embryonic Stem Cells Using Recombinase-mediated Cassette Exchange

Published on: April 27, 2017

10.9K

科学领域:

  • 细胞生物学 细胞生物学
  • 分子生物学分子生物学
  • 生物化学 生物化学

背景情况:

  • 细胞命运的决定是由复杂的分子机械控制的.
  • 识别调节这些过程的关键成分对于理解发育和疾病至关重要.

研究的目的:

  • 设计和测试一个工程细胞命运控制器,NanogBiD,用于增强体细胞重编程.
  • 为了阐明纳米BiD促进细胞命运过渡的分子机制.

主要方法:

  • SS18 的 BRG1 相互作用域 (BiD) 与 Nanog 的融合,产生 NanogBiD.
  • 在各种条件下测试NanogBiD在小鼠体细胞重编程中的效率.
  • 机理学研究涉及染色体可访问性测试和基因表达分析.

主要成果:

  • 工程NanogBiD与原生Nanog相比,在小鼠体细胞重编程中表现出显著更高的效率.
  • 纳米BiD通过招募Brg/Brahma关联因子 (BAF) 复合体来促进细胞命运过渡.
  • 这种招募调节了染色质的可访问性,并重组了特定于细胞状态的增强剂,导致多能性基因的早期激活.

结论:

  • 像NanogBiD这样的工程染色体调节器为精确的细胞命运工程提供了强大的工具.
  • 这些发现表明,在基于细胞的新兴疗法领域有潜在的治疗应用.
  • 需要进一步的研究来评估这种方法在其他物种.